Drug Trial Radar · NCT02921022
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
110
Planned (sponsor's estimate)
Start
Oct 2016
Primary completion
Oct 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Halozyme Therapeutics; Miami Cancer Institute
- First posted
- Sep 30, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food and Drug Administration (FDA) has not approved the marketing or sale of PEGPH20, but have authorized its use in research studies with humans. PEGPH20 could shrink the cancer but it also can cause side effects. PEGPH20 is an enzyme that breaks down a specific tissue component called hyaluronan produced by some tumors. Pancreatic tumors often have a large amount of hyaluronan. The removal of hyaluronan from tumors may decrease tumor growth.
Conditions
- Pancreatic Cancer
- Advanced Pancreatic Ductal Adenocarcinoma
Interventions
GemcitabineDrug
Nab-paclitaxelDrug
PEGPH20Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- rate of symptomatic TE eventsTime frame: 1 year
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Hartford Healthcare Cancer Institute @ Hartford Hospital
Hartford, Connecticut
Miami Cancer Institute
Miami, Florida
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth
Middletown, New Jersey
Memorial Sloan Kettering Bergen
Montvale, New Jersey
Memorial Sloan Kettering Commack
Commack, New York
Memorial Sloan Kettering Westchester
Harrison, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Memorial Sloan Kettering Nassau
Uniondale, New York
Lehigh Valley Health Network
Allentown, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.